Invited commentary: When bad genes look good - APOE*E4, cognitive decline, and diagnostic thresholds

American Journal of Epidemiology

Volumn 165, Issue 11, 2007, Pages 1239-1246

  Glymour, M Maria ^a,b,c  

^a Columbia University ^*  (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c NONE   (United States)

Author keywords

Apolipoproteins E; Bias (epidemiology); Cognition disorders; Cohort studies; Dementia; Disease progression

Indexed keywords

APOENZYME; APOLIPOPROTEIN E4;

ALLELE; EPIDEMIOLOGY; MORTALITY; PROBABILITY; RISK FACTOR;

ALZHEIMER DISEASE; COGNITIVE DEFECT; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; GENETIC ANALYSIS; HUMAN; MORTALITY; PATHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT; RISK FACTOR; AGED; DEMENTIA; EPIDEMIOLOGY; FEMALE; GENETICS; METHODOLOGY; NONLINEAR SYSTEM; NOTE; SURVIVAL; UNCERTAINTY; UNITED STATES;

AGED; APOLIPOPROTEIN E4; BIAS (EPIDEMIOLOGY); COGNITION DISORDERS; DEMENTIA; DISEASE PROGRESSION; FEMALE; HUMANS; NONLINEAR DYNAMICS; RESEARCH DESIGN; RISK FACTORS; SURVIVAL ANALYSIS; UNCERTAINTY; UNITED STATES;

EID: 34447266414     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwm092     Document Type: Review

References (14)

1. Tyas SL, Salazar JC, Snowdon DA, et al. Transitions to mild cognitive impairment, dementia, and death: findings from the Nun Study. Am J Epidemiol 2007;165:1231-8.
2. Yanez ND, Kronmal RA, Shemanski LR. The effects of measurement error in response variables and tests of association of explanatory variables in change models. Stat Med 1998;17:2597-606.
3. Yanez ND, Kronmal RA, Shemanski LR, et al. A regression model for longitudinal change in the presence of measurement error. Ann Epidemiol 2002;12:34-8.
4. Glymour MM, Weuve J, Berkman LF, et al. When is baseline adjustment useful in analyses of change? An example with education and cognitive change. Am J Epidemiol 2005;162:267-78.
5. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997;278:1349-56.
6. Martins CA, Oulhaj A, de Jager CA, et al. APOE alleles predict the rate of cognitive decline in Alzheimer disease. A nonlinear model. Neurology 2005;65:1888-93.
7. Stern Y, Brandt J, Albert M, et al. The absence of an apolipoprotein epsilon 4 allele is associated with a more aggressive form of Alzheimer's disease. Ann Neurol 1997;41:615-20.
8. Gomez-Isla T, West HL, Rebeck GW, et al. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Ann Neurol 1996;39:62-70.
9. Frisoni GB, Govoni S, Geroldi C, et al. Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol 1995;37:596-604.
10. Jonker C, Schmand B, Lindeboom J, et al. Association between apolipoprotein E epsilon 4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Arch Neurol 1998;55:1065-9.
11. Hirono N, Hashimoto N, Yasuda M, et al. Accelerated memory decline in Alzheimer's disease with apolipoprotein epsilon 4 allele. J Neuropsychiatry Clin Neurosci 2003;15:354-8.
12. Peto R. The horse-racing effect. (Letter). Lancet 1981;2:467-8.
13. Hernán MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiology 2004;15:615-25.
14. Camicioli R, Kryscio R. Nature throws curveballs. APOE and nonlinear decline in Alzheimer disease. Neurology 2005;65:1855-6.